Clinical characteristics and medication use among premenopausal women with osteoporosis and low BMD: The experience of an osteoporosis referral center

Journal of Women's Health

Volumn 18, Issue 1, 2009, Pages 79-84

  Cohen, Adi ^a   Fleischer, Jessica ^a   Freeby, Matthew J ^a   McMahon, Donald J ^a   Irani, Dinaz ^b   Shane, Elizabeth ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; GLUCOCORTICOID;

ADULT; AMENORRHEA; ANOREXIA NERVOSA; ARTICLE; BONE DENSITY; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HIP; HUMAN; IDIOPATHIC OSTEOPOROSIS; INJURY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OSTEOPOROSIS; PREMENOPAUSE; PRESCRIPTION; PRIORITY JOURNAL; SECONDARY OSTEOPOROSIS; SHORT STATURE; SPINE;

ABSORPTIOMETRY, PHOTON; ADULT; AGE FACTORS; ANTHROPOMETRY; BODY HEIGHT; BODY WEIGHT; BONE DENSITY; DIPHOSPHONATES; DRUG UTILIZATION REVIEW; FEMALE; FRACTURES, BONE; HIP; HOSPITALS, UNIVERSITY; HUMANS; MIDDLE AGED; NEW YORK CITY; OSTEOPOROSIS; PREMENOPAUSE; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; RISK FACTORS; SPINE; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 58149389473     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2008.0887     Document Type: Article

References (28)

1. Khan AA, Syed Z. Bone densitometry in premenopausal women: Synthesis and review. J Clin Densitometry 2004;7:85-92.
2. Khosla S, Lufkin EG, Hodgson SF, Fitzpatrick LA, Melton LJ 3rd. Epidemiology and clinical features of osteoporosis in young individuals. Bone 1994;15:551-555.
3. Moreira Kulak CA, Schussheim DH, McMahon DJ, et al. Osteoporosis and low bone mass in premenopausal and perimenopausal women. Endocr Pract 2000;6:296-304.
4. Lindsay R. Bone mass measurement for premenopausal women. Osteoporos Int 1994;4(Suppl 1):39-41.
5. Khan A. Premenopausal women and low bone density. Can Fam Physician 2006;52:743-747.
6. Derk CT. Osteoporosis in females prior to menopause: Current concepts regarding definition, screening and management. Minerva Med 2006;97:479-486.
7. Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002;359:1929-1936.
8. Lewiecki EM, Kendler DL, Kiebzak GM, et al. Special report on the official positions of the International Society for Clinical Densitometry. Osteoporos Int 2004;15:779-784.
9. Peris P, Guanabens N, Martinez de Osaba MJ, et al. Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women. Semin Arthritis Rheum 2002;32:64-70.
10. Khosla S, Riggs BL, Atkinson EJ, et al. Effects of sex and age on bone microstructure at the ultradistal radius: A population-based noninvasive in vivo assessment. J Bone Miner Res 2006;21:124-131.
11. Seeman E. Clinical review 137: Sexual dimorphism in skeletal size, density, and strength. J Clin Endocrinol Metab 2001;86:4576-4584.
12. Patlas N, Golomb G, Yaffe P, Pinto T, Breuer E, Ornoy A. Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology 1999;60:68-73.
13. Minsker DH, Manson JM, Peter CP. Effects of the bisphosphonate, alendronate, on parturition in the rat. Toxicol Appl Pharmacol 1993;121:217-223.
14. Chan B, Zacharin M. Maternal and infant outcome after pamidronate treatment of polyostotic fibrous dysplasia and osteogenesis imperfecta before conception: A report of four cases. J Clin Endocrinol Metab 2006;91:2017-2020.
15. O'Sullivan SM, Grey AB, Singh R, Reid IR. Bisphosphonates in pregnancy and lactation-associated osteoporosis. Osteoporos Int 2006;17:1008-1012.
16. Biswas PN, Wilton LV, Shakir SA. Pharmacovigilance study of alendronate in England. Osteoporos Int 2003;14:507-514.
17. Munns CF, Rauch F, Ward L, Glorieux FH. Maternal and fetal outcome after long-term pamidronate treatment before conception: A report of two cases. J Bone Miner Res 2004;19:1742-1745.
18. Wu F, Mason B, Horne A, et al. Fractures between the ages of 20 and 50 years increase women's risk of subsequent fractures. Arch Intern Med 2002;162:33-36.
19. Rothberg AD, Matshidze PK. Perimenopausal wrist fracture - An opportunity for prevention and management of osteoporosis. S Afr Med J 2000;90:1121-1124.
20. Hosmer WD, Genant HK, Browner WS. Fractures before menopause: A red flag for physicians. Osteoporos Int 2002;13:337-341.
21. Honkanen R, Tuppurainen M, Kroger H, Alhava E, Puntila E. Associations of early premenopausal fractures with subsequent fractures vary by sites and mechanisms of fractures. Calcif Tissue Int 1997;60:327-331.
22. Wigderowitz CA, Cunningham T, Rowley DI, Mole PA, Paterson CR. Peripheral bone mineral density in patients with distal radial fractures. J Bone Joint Surg Br 2003;85:423-425.
23. Cohen A, Becker CB. Epidemiology and etiology of premenopausal osteoporosis. In: Rose BD, ed. UpToDate. Waltham, MA: 2007.
24. Hui SL, Slemenda CW, Johnston CC Jr. Age and bone mass as predictors of fracture in a prospective study. J Clin Invest 1988;81:1804-1809.
25. Cohen A, Becker CB. Evaluation and treatment of premenopausal osteoporosis. In: Rose BD, ed. UpToDate. Waltham, MA: 2007.
26. Leib ES. Treatment of low bone mass in premenopausal women: When may it be appropriate? Curr Osteoporos Rep 2005;3:13-18.
27. Peris P, Monegal A, Martinez MA, Moll C, Pons F, Guanabens N. Bone mineral density evolution in young premenopausal women with idiopathic osteoporosis. Clin Rheumatol 2007;26:958-961.
28. Hung LK, Wu HT, Leung PC, Qin L. Low BMD is a risk factor for low-energy Colles' fractures in women before and after menopause. Clin Orthop Rel Res 2005;435:219-225.